Edgestream Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Edgestream Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3M	Buy	+8,208	New	+$1.11M	0.04%	618
2026 Q1	–	Sell	-7,266	Closed	-$886K	–	1148
2025 Q4	$886K	Buy	7,266 +3,500	+93%	+$401K	0.02%	719
2025 Q3	$377K	Sell	3,766 -2,578	-41%	-$232K	0.01%	767
2025 Q2	$526K	Buy	+6,344	New	+$506K	0.01%	724
2024 Q4	–	Sell	-13,171	Closed	-$1.3M	–	1128
2024 Q3	$1.3M	Buy	13,171 +3,103	+31%	+$305K	0.06%	516
2024 Q2	$933K	Buy	10,068 +6,528	+184%	+$585K	0.04%	540
2024 Q1	$336K	Buy	+3,540	New	+$328K	0.02%	697
2023 Q4	–	Sell	-29,030	Closed	-$2.12M	–	1104
2023 Q3	$2.12M	Buy	29,030 +21,081	+265%	+$1.68M	0.17%	179
2023 Q2	$661K	Buy	7,949 +132	+2%	+$11K	0.06%	467
2023 Q1	$596K	Buy	+7,817	New	+$649K	0.07%	376

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Edgestream Partners's XBI Position: Q2 2026 in Review

Edgestream Partners opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 8,208 shares worth $1.3M. The stake represents 0.04% of the portfolio and ranks #618 among its holdings. This is a return to the name: Edgestream Partners previously reported a position in XBI as recently as Q4 2025.

Edgestream Partners first reported a position in XBI in Q1 2023 and has held it in 10 quarters since. The position peaked at $2.12M in Q3 2023. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Edgestream Partners held 8,208 shares of State Street SPDR S&P Biotech ETF worth $1.3M as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Edgestream Partners position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.04% of Edgestream Partners's portfolio in Q2 2026, its #618 holding.
Edgestream Partners first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and has held it in 10 quarters since.
Edgestream Partners's State Street SPDR S&P Biotech ETF position peaked at $2.12M in Q3 2023.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.